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Abstract
Introduction: The natural history of patients with spontaneous parathyroid necrosis is unknown.
In this case report we describe the clinical course, laboratory, radiographic, bone densitometry
tests, parathyroid ultrasonography and scintigraphy examinations of a patient performed over a
period of eight years after she first presented with a sudden episode of spontaneous resolution of
primary hyperparathyroidism (PHPT).
Case presentation: A 24-year-old woman with a clinical history and laboratory and radiographic
tests compatible with PHPT suffered a sudden episode of cervical pain and presented with clinical
evidence of hypocalcemia. Biopsy of a cervical nodule revealed necrotic material compatible with
ischemia of the parathyroid. The follow-up of the patient presented four distinct phases: the first,
which lasted two years, was compatible with a period of bone hunger during which it was necessary
to introduce calcitriol and calcium carbonate. During this period, the patient showed bone mass
gain. The second phase was characterized by normalization of calcium and parathyroid hormone
levels and its end was difficult to define. During the third phase there was a recurrence of
hypercalcemia associated with elevated parathyroid hormone (PTH) levels and loss of bone mass.
The last phase corresponded to the interval after parathyroidectomy, which was characterized by
normalization of serum levels of calcium and PTH, as well as bone mass gain.
Conclusion: This case report indicates that spontaneous resolution of PHPT by adenoma necrosis
is potentially temporary. Thus, in cases in which a conservative approach is chosen, clinical and
laboratory follow-up is indispensable. Bone mass measurement is a useful tool in the follow-up of
these cases. However, this option exposes the patient to a potential roller-coaster ride of bone
mass gain and loss, whose long term consequences are still unknown.
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Introduction
Although the natural history of primary hyperparathy-
roidism (PHPT) is incompletely understood, in many
cases the calcium level remains stable when monitored on
a regular basis [1,2]. In parallel, over the last two decades
the number of reported cases that do not follow this pat-
tern has increased [3]. The first case of cyclic PHPT was
recently reported [4] and sporadic cases of spontaneous
resolution due to apoplexy of parathyroid adenomas have
been reported more frequently [3,5,6]. In the latter situa-
tion most patients were submitted to early surgery or were
followed for as long as 30 months but this did not include
bone mass evaluation.
In this case study we report the details of a patient who
presented with spontaneous remission of PHPT and was
followed for eight years after the apoplexy episode, at
which time she presented with recurrence of hypercal-
cemia. In this case, in addition to obtaining clinical and
laboratory documentation, the authors prospectively eval-
uated the patient's bone densitometry.
Case presentation
In 1998, a 24-year-old white female attended the endo-
crinology outpatient clinic of the Medical Center of the
School of Medicine of Ribeirão Preto, USP, with com-
plaints of bone pain and muscle weakness of ten years
duration. She reported pain intensification in the upper
and lower limbs for the past two years. In addition, over
the past year she had started to develop nocturia, asthenia,
and weight loss of about 8 kg. She also had had episodes
of renal colic. She reported that long bone radiography
had shown evidence of bone lesions. According to the
patient, a bone biopsy had revealed the presence of a
benign tumor. When seen at our outpatient clinic, the
patient was found to be in good general condition, with-
out any detectable cervical nodule. The patient had
already had the following tests: calcium = 11.9 mg/dl,
phosphorus (Pi) = 1.8 mg/dl, and alkaline phosphatase
(ALP) = 1642 U/L. The initial by in our service confirmed
the previous biochemical profile: calcium = 11.9 mg/dl
(8.5–10.5 mg/dl), phosphorus = 1.7 mg/dl (2.5–4.5 mg/
dl), ALP = 2352 U/L (40–160 U/L), creatinine = 0.5 mg/dl
(0.7–1.1 mg/dl) chloride = 106 mEq/L (98–106 mEq/L),
ionized calcium Ca++ = 1.57 mmol/L (1.14–1.29 mmol/
L), and chloride/Pi ratio = 62.3 (<30). Radiotransparent
circular images with well defined margins without periph-
eral sclerosis were observed in the middle diaphyseal third
of the left femur and left humerus and in the proximal dia-
physeal third of the right tibia. Hand and skull radiogra-
phies only revealed osteopenia. One week after our first
evaluation, she started to experience paresthesia in the
hands, face and limbs and she experienced an episode of
hand muscle contraction. Because of the persistence of
paresthesia, the patient returned to our service, when
Chvostek's sign was observed. Upon clinical examination,
a painless nodule was palpated in the left lobe of the thy-
roid. Table 1 shows the laboratory evaluation. Cervical
ultrasound revealed an enlarged left lobe of the thyroid
with a nodular image measuring 7.4 cm3, with a heteroge-
neous echotexture and containing areas of cystic degener-
ation. Scintigraphic examination of the parathyroid with
sestamibi did not show abnormal uptake. Magnetic reso-
nance examination revealed a nodule (1.9 cm) with a
cystic component with defined contours, compatible with
a lesion of the parathyroid (Figure 1). Cytological exami-
nation showed a large amount of cell debris, few macro-
phages and neutrophils and numerous clusters of small
anucleated necrotic cells or cells rarely containing
pyknotic nuclei.
It was decided to use a noninvasive approach, using 1000
mg elemental calcium and 0.5 μg calcitriol/day (Roche,
São Paulo, SP, Brazil). The neuromuscular symptoms of
Table 1: Laboratory work-up upon patient admission
Results (reference)
Calcium (mg/dl) 6.8 (8.5–10.5)
Ionized calcium (mmol/L) 0.95 (1.14–1.29)
PTH (pg/ml) 110 (6–67)
T4L (ng/dl) 0.8 (0.7 – 1.7)
TSH (UI/ml) 1.5 (0.4 – 4.0)
ALP (U/L) 847 (40–160)
Chloride (mEq/L) 106 (98–107)
Magnesium (mEq/L) 2.0 (1.6–2.6)
Creatinine (mg/dl) 0.4 (0.7–1.0)
LH (mUI/ml) 2.0 (0.3 – 13)
FSH (mUI/ml) 14.0 (13 – 30)
Prolactin (ng/dl) 14.0 (<25.0)
Plasma cortisol (μg/dl) 6.4 (5.0 – 20.0)
25-Hydroxyvitamin D (ng/ml) 11.0 (15.0 – 80.0)
1,25(OH)2D (pg/ml) 210 (15.0 – 60.0)Journal of Medical Case Reports 2007, 1:139 http://www.jmedicalcasereports.com/content/1/1/139
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the patient were relieved and she continued to use this
medication for 3 years. During this period her total cal-
cium levels were always normal (8.0 to 10.4 mg/dl),
although her Ca++ levels were discretely low for 2 years
(1.0 to 1.13 mmol/L) and then normal, during the third
year (1.2 to 1.24 mmol/L). Pi levels were always normal
(3.0 to 4.1 mg/dl) and PTH level was high during the first
year (89.5 to 159 pg/ml) and normal during the second
and third years (24–56 pg/ml). ALP levels progressively
fell, ranging from 781 down to 317 U/L during the first
year, from 266 to 94 U/L during the second year, and from
80 to 57 U/L during the third year. Calciuria was low
throughout the three-year period (12.9 to 75 mg/24
hours). During the fourth year, calcitriol was first discon-
tinued, soon followed by discontinuation of calcium as
the patient started to present calcium levels in the upper
normal limit. Between 2002 and 2004, the patient pre-
sented fluctuation of total calcium levels from 9.1 to 10.6
mg/dl, of Ca++ from 1.21 to 1.44 mmol/L, of Pi from 2.0
to 3.5 mg/dl, of calciuria from 78,2 to111 mg/24 hours,
and of PTH from 31 to 87 pg/ml. In 2004, 25-hydroxyvi-
tamin D level was 19 ng/ml. In 2005 the patient showed
a continuous tendency to elevation of calcemia, and par-
athyroidectomy was indicated. However, the patient
agreed to submit to the procedure only in the middle of
2006. Figure 2A &2B shows the variation in laboratory
measurements between 2005 and 2006.
Parathyroid scintigraphy with sestamibi in 2003 and
before surgery did not show abnormal uptake of the radi-
opharmaceutical. Ultrasound showed a reduction of the
nodule only in 2006, when its size was 0.53 cm3.
Bone mineral densitometry (BMD) was obtained using
two different instruments. In 2000 and 2001, the patient
showed bone mass gain in lumbar spine (3.3%) and fem-
oral neck (7.4%), (Figure 2C). These examinations were
performed with a Sophos L-XRA instrument (Sophos,
Paris, France), which did not include software for the fore-
arm. Starting in 2003, the examinations were performed
with Hologic instruments (4500 W, Waltham, MA, USA,
QDR System Software Version 11.2). In 2003 and 2006
BMD was: a) L1–L4 = 0.846 and 0.787 g/cm2; b) total hip
= 0.984 and 0.914 g/cm2 and c) 1/3 distal radius = 0.475
and 0.423, respectively (Figure 2C).
The preoperative results obtained for the patient were as
follows: total calcium= 10.7 mg/dl, Ca++ = 1.38 mmol/L,
phosphorus = 3.1 mg/dl, ALP = 186 U/L, and PTH = 73
pg/ml.
Left inferior parathyroid adenoma Figure 1
Left inferior parathyroid adenoma. Axial MR imaging scans (07/1998) weighted in T1 (A) and T2 (B) show a spontaneous 
hyperintense and well defined round lesion in both T1- and T2-weighted in the left-inferior parathyroid adenoma region 
(arrow). There is a hypointense lesion with a halo in the T2-weighted image which can represent degradation products of 
hemoglobin (arrowheads).
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Clinical investigation Figure 2
Clinical investigation. Evolution of serum levels of (A) PTH and calcium; (B) alkaline phosphatase and phosphorus and (C) 
bone mineral density of total hip, femoral neck, lumbar spine and distal third of radius (2000–2001, Sophos and 2003–2007 
Hologic 4500 W equipment) during patient follow-up.
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The patient underwent conventional surgery with bilateral
neck exploration under general anesthesia in July 2006,
when an adenoma was located in the left inferior pole of
the thyroid. A blood sample was collected 10 minutes
after the resection of the suspected hyperfunctioning par-
athyroid tissue for later determination of serum PTH by a
conventional method. The result (PTH = 5.9 pg/ml) sup-
ported the success of the surgical procedure. Anato-
mopathological examination showed a benign
proliferation of parathyroid cells, the presence of fibrosed
tissue with hemosiderin deposition (old hemorrhage),
and a cavity surrounded by fibrous walls containing mac-
rophages, lymphocytes, multinucleated giant cells, cho-
lesterol crystals and cell debris (Figure 3). Postoperatively
the patient showed normalization of serum total calcium
levels (8.9 mg/dl), Ca++ (1.15 mmol/L), phosphorus (3.1
mg/dl), albumin (4.3 g/dl) and ALP (165.0 U/L). In addi-
tion, we observed significant increase in BMD in all sites
evaluated six months after parathyroidectomy (L1–L4
6.5%, 1/3 of radius 5.4%, femoral neck 5.1% and total hip
4.1%), Figure 2C.
Discussion
In view of the current status of primary hyperparathy-
roidism as a frequent disease that is usually asympto-
matic, a challenge regarding the management of patients
with this disease is to identify the best treatment option,
considering that surgery is the only curative option [7].
After almost two decades of surveillance of patients in a
chronic PHPT state, it is necessary to point out other
aspects that used to be imperceptible and/or rare and that
today represent new challenges regarding the treatment of
these patients. Patients with PHPT presenting with nor-
Photomicrograph of the parathyroid adenoma Figure 3
Photomicrograph of the parathyroid adenoma. Image showing extensive areas of necrosis represented by eosinophilic 
amorphous material, with fibrosis, and a few remaining clusters of tumoral cells (Hematoxylin-Eosin, ×100).Journal of Medical Case Reports 2007, 1:139 http://www.jmedicalcasereports.com/content/1/1/139
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mal serum PTH levels have been occasionally reported
[8]. However, because of its frequency, the occurrence of
spontaneous PHPT resolution by apoplexy of parathyroid
adenomas is even more important. Onoda et al. [9] in
1994 stated that only 25 such cases had been reported.
However, the frequency of this problem has increased and
at least 26 additional similar cases have been reported
since that time [3]. These patients either submitted to sur-
gery early [5,6], or were followed for about 3 years, and
there is no information about a natural evolution moni-
tored over a more prolonged time with ultrasonographic
and scintigraphic evaluation. In particular, none of these
studies reported the evolution of BMD in these patients.
In this case report we describe the evolution of all of these
parameters over a period of 8 years in a patient who pre-
sented with spontaneous remission of PHPT followed by
recurrence of the functional disorder at the end of this 8
year period. Based on this case, it is possible to extract
important information regarding appropriate clinical and
surgical conduct and the most appropriate timing for sur-
gery.
The first aspect to be emphasized in this case is that punch
biopsy of the parathyroid, at the time of adenoma infarc-
tion, associated with anatomopathologic examination
after parathyroidectomy of the same gland, showed evi-
dence of previous necrosis and benign proliferation of
parathyroid cells indicating recurrence of parathyroid ade-
noma.
The first phase, which followed the infarction of the par-
athyroid adenoma, is compatible with a state of bone
hunger, which is expected in patients with the important
bone disorder of PHPT, as demonstrated in the present
case by the elevation of alkaline phosphatase and the
clearly visible radiologic changes of PHPT. During this
period PTH remained elevated as a physiological adapta-
tion to the increased calcium utilization by bone and
bone mass recomposition. However, the periods of appar-
ent normalization of parathyroid functioning that follow
this phase and the later recrudescence of PHPT are diffi-
cult to delimit. This is largely due to the fluctuation of
serum calcium and PTH levels that may occur in these
patients. The undefined signs and symptoms may pro-
duce an undesirable loss of bone mass and non-quantifi-
able changes in bone quality that may not be fully
corrected after definitive surgery. This aspect should be
particularly considered in order to define the most appro-
priate therapeutic course. In this reported case, measure-
ment of bone mass proved to be a sensitive and objective
procedure for the demonstration of disease activity and
was useful regarding the decision about the need for sur-
gery.
Currently, different centers are performing parathyroid
surgery by minimally invasive procedures (MIP) with
huge success, thus providing a less traumatic and attrac-
tive alternative therapy for PHPT [10,11]. The standardi-
zation of these procedures and of the examinations that
usually are associated with these procedures, such as opti-
mizing parameters of parathyroid localization (intraoper-
ative scintigraphic scan) and to assure surgical success
(intraoperative determination of quick PTH) will allow
the use of these therapeutic options on a large scale [12].
However, in relation to the patient described herein there
are some concerns about doing a MIP: a) the patient had
a negative scan with sestamibi, b) the possible presence of
more than one parathyroid nodule and c) the previous
parathyroid apoplexy could result in morphological alter-
ations secondary to hemorrhage. It was considered that
this patient should be included in the group for which
conventional surgery would be more appropriate. Accord-
ing to Micolli et al., (2000) [10] approximately 30% of the
patients with PHPT are suitable for conventional surgery.
Conclusion
This case indicates that the apparent cure that follows
necrosis of a parathyroid adenoma is potentially tempo-
rary. All data suggest that an early surgical approach is
acceptable for these patients. Conservative management,
which involves periodic clinical and laboratory examina-
tions, definitely results in higher costs. Our data also sug-
gest that in addition to calcium and PTH measurements,
bone densitometry is a most useful tool for the follow up
of these patients.
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